BCM
VCEL icon

Bayesian Capital Management’s Vericel Corp VCEL Stock Holding History

Bayesian Capital Management’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,963
Closed -$274K – 1058
2024
Q2 		$274K Buy
+5,963
New +$281K 0.03% 528
2019
Q2 		– Sell
-22,700
Closed -$397K – 684
2019
Q1 		$397K Sell
22,700
-23,900
-51% -$437K 0.08% 341
2018
Q4 		$811K Buy
+46,600
New +$697K 0.17% 196
2018
Q2 		– Sell
-24,000
Closed -$239K – 744
2018
Q1 		$239K Buy
+24,000
New +$199K 0.06% 453

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayesian Capital Management's VCEL Position: Q3 2024 in Review

Bayesian Capital Management sold out of Vericel Corp (VCEL) in Q3 2024, closing a stake of 5,963 shares — an estimated $274K sold.

Bayesian Capital Management first reported a position in VCEL in Q1 2018 and held it in 4 quarters. The position peaked at $811K in Q4 2018. 268 funds tracked by Wall St. Rank hold VCEL as of Q3 2024.

  • Bayesian Capital Management reported no remaining Vericel Corp position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 5,963 Vericel Corp shares in Q3 2024, an estimated $274K.
  • Bayesian Capital Management first reported a position in Vericel Corp in Q1 2018 and held it in 4 quarters.
  • Bayesian Capital Management's Vericel Corp position peaked at $811K in Q4 2018.
  • 268 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.